H1B Report
Side-by-side comparison

Apogee Medical Group, New York, PC vs WIPRO LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Apogee Medical Group, New York, PC
TXRank #FEIN 27-1602881
Entity B
WIPRO LIMITED
NJRank #6FEIN 98-0154401

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricApogee Medical Group, New York, PCWIPRO LIMITED
Total filings31972,392
Certified %86.83%91.61%
Denied %0.94%0.37%
Withdrawn %5.96%1.37%
Cert-withdrawn %6.27%6.64%
Rank#6
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateTXNJ

Outcomes — Apogee Medical Group, New York, PC

DOL case-status mix.

Outcome breakdown: Certified 86.8%, Cert-withdrawn 6.3%, Withdrawn 6.0%, Denied 0.9%
Outcome breakdown
OutcomeShare
Certified86.8%
Cert-withdrawn6.3%
Withdrawn6.0%
Denied0.9%
Certified86.8%
Cert-withdrawn6.3%
Withdrawn6.0%
Denied0.9%

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 91.6%, Cert-withdrawn 6.6%, Withdrawn 1.4%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Apogee Medical Group, New York, PC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20106
FY201120
FY201237
FY201312
FY201427
FY201518
FY201627
FY201730
FY201830
FY201945
FY20200
FY20210
FY20220
FY20235
FY202420
FY202529
FY202613
WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,039
FY20113,025
FY20127,031
FY20136,574
FY20148,104
FY201511,824
FY201610,254
FY20175,012
FY20186,067
FY20194,154
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,850

Top 5 occupations — Apogee Medical Group, New York, PC

Top 5 occupations — WIPRO LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.